Results 181 to 190 of about 46,553 (219)
Some of the next articles are maybe not open access.
Chronic inflammatory demyelinating polyneuropathy and diabetes
Journal of Neurology, Neurosurgery & Psychiatry, 2020CIDP is a most common chronic immune-mediated demyelinating neuropathy, but still a rare disease; the reported prevalence ranges from 0.8 to 8.9 per 100 000 people.1 The different prevalence among the studies is partly dependent on diagnostic criteria and CIDP subtypes.
Satoshi Kuwabara +2 more
openaire +2 more sources
Dysautonomic polyneuropathy as a variant of chronic inflammatory “demyelinating” polyneuropathy?
Clinical Autonomic Research, 2016This report describes the clinical course over almost one decade of a male patient presenting with immune-mediated pure autonomic neuropathy resembling a distinct variant of chronic dysimmune polyneuropathies. We suppose autoantibodies directed against epitopes on autonomic axons or neurons causative for the symptoms.
Hans-Heinrich, Wolf +3 more
openaire +2 more sources
The spectrum of chronic inflammatory demyelinating polyneuropathy
Journal of the Neurological Sciences, 2000Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) were proposed by an Ad Hoc Subcommittee of the American Academy of Neurology (AAN) in 1991, and since then these criteria have been widely used in clinical studies.
F T, Rotta +5 more
openaire +2 more sources
Demyelinating polyneuropathy in eosinophilia–myalgia syndrome
Muscle & Nerve, 1992AbstractEosinophilia–myalgia syndrome (EMS) is a newly recognized disorder, characterized by myalgia, weakness, scleroderma‐like changes, and eosinophilia. EMS is associated with lots of L‐tryptophan allegedly contaminated with byproducts of the manufacturing process.
P D, Donofrio +6 more
openaire +2 more sources
Treatment of chronic inflammatory demyelinating polyneuropathy
The Italian Journal of Neurological Sciences, 1998The management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the main topic of this review. A few comments will also be made about treatment of the demyelinating form of paraproteinaemic demyelinating polyneuropathy (PDN) and of multifocal motor neuropathy (MMN).
COMI , GIANCARLO, ROVERI L.
openaire +3 more sources
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
Current Neurology and Neuroscience Reports, 2015Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the acquired demyelinating neuropathies and is considered to be immune mediated. Diagnosis is typically based on clinical history, neurologic examination, electrophysiologic studies, CSF studies, and pathologic examination.
Inna, Kleyman, Thomas H, Brannagan
openaire +2 more sources
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
Current Treatment Options in Neurology, 2010Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated, non-length-dependent polyradiculoneuropathy that is progressive or relapsing over a period of at least 8 weeks, often evolving over time to a relatively symmetric pattern.
Eliza E, Robertson, Peter D, Donofrio
openaire +2 more sources
Atypical chronic inflammatory demyelinating polyneuropathies
Journal of Neurology, Neurosurgery & Psychiatry, 2018Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy progressive for more than 2 months, including several clinical subtypes.1 2 In 1975, Dyck et al 3 described the classical prototype of CIDP, and emphasised that a prominent clinical feature is weakness of the proximal and distal muscles about equally which is very
Satoshi Kuwabara +2 more
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy.
International journal of tissue reactions, 1985In 12 cases of CIDP under surveillance for 14 years, the main nerve biopsy findings were endoneural oedema and demyelination of nerve fibres. IgM deposition was found in 1 patient and IgG deposits in another. Electron microscopy revealed proliferation of the Schwann cells and mononuclear cell infiltration.
RIZZUTO, Nicolo', SIMONATI, Alessandro
openaire +2 more sources
Acquired Demyelinating Polyneuropathies
Seminars in Neurology, 1987R P, Lisak, M J, Brown
openaire +2 more sources

